Literature DB >> 18314068

Targeted molecular imaging in oncology: focus on radiation therapy.

Sridhar Nimmagadda1, Eric C Ford, John W Wong, Martin G Pomper.   

Abstract

Anatomically based technologies (computed tomography scans, magnetic resonance imaging, and so on) are in routine use in radiotherapy for planning and assessment purposes. Even with improvements in imaging, however, radiotherapy is still limited in efficacy and toxicity in certain applications. Further advances may be provided by technologies that image the molecular activities of tumors and normal tissues. Possible uses for molecular imaging include better localization of tumor regions and early assay for the radiation response of tumors and normal tissues. Critical to the success of this approach is the identification and validation of molecular probes that are suitable in the radiotherapy context. Recent developments in molecular-imaging probes and integration of functional imaging with radiotherapy are promising. This review focuses on recent advances in molecular imaging strategies and probes that may aid in improving the efficacy of radiotherapy.

Entities:  

Mesh:

Year:  2008        PMID: 18314068      PMCID: PMC2288529          DOI: 10.1016/j.semradonc.2007.10.009

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  206 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Targeted in vivo imaging of angiogenesis: present status and perspectives.

Authors:  Yearn Seong Choe; Kyung-Han Lee
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

3.  Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas.

Authors:  S Rege; A A Safa; L Chaiken; C Hoh; G Juillard; H R Withers
Journal:  Am J Clin Oncol       Date:  2000-04       Impact factor: 2.339

4.  [11C]Choline as a potential PET marker for imaging of breast cancer athymic mice.

Authors:  Qi-Huang Zheng; K Lee Stone; Bruce H Mock; Kathy D Miller; Xiangshu Fei; Xuan Liu; Ji-Quan Wang; Barbara E Glick-Wilson; George W Sledge; Gary D Hutchins
Journal:  Nucl Med Biol       Date:  2002-11       Impact factor: 2.408

Review 5.  Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging.

Authors:  Shuang Liu
Journal:  Mol Pharm       Date:  2006 Sep-Oct       Impact factor: 4.939

6.  Choline transporter as a novel target for molecular imaging of cancer.

Authors:  Toshihiko Hara; Aditya Bansal; Timothy R DeGrado
Journal:  Mol Imaging       Date:  2006 Oct-Dec       Impact factor: 4.488

Review 7.  Imaging hypoxia and angiogenesis in tumors.

Authors:  Joseph G Rajendran; Kenneth A Krohn
Journal:  Radiol Clin North Am       Date:  2005-01       Impact factor: 2.303

8.  Cellular sources of thymidine nucleotides: studies for PET.

Authors:  A F Shields; D V Coonrod; R C Quackenbush; J J Crowley
Journal:  J Nucl Med       Date:  1987-09       Impact factor: 10.057

9.  Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.

Authors:  Patrick M Winter; Shelton D Caruthers; Andrea Kassner; Thomas D Harris; Lori K Chinen; John S Allen; Elizabeth K Lacy; Huiying Zhang; J David Robertson; Samuel A Wickline; Gregory M Lanza
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

Review 10.  Translational molecular imaging for cancer.

Authors:  Martin G Pomper
Journal:  Cancer Imaging       Date:  2005-11-23       Impact factor: 3.909

View more
  14 in total

Review 1.  Multimodality image registration with software: state-of-the-art.

Authors:  Piotr J Slomka; Richard P Baum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

Review 2.  Functional and molecular image guidance in radiotherapy treatment planning optimization.

Authors:  Shiva K Das; Randall K Ten Haken
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

3.  Radiation-induced tumor neoantigens: imaging and therapeutic implications.

Authors:  Christopher D Corso; Arif N Ali; Roberto Diaz
Journal:  Am J Cancer Res       Date:  2011-01-25       Impact factor: 6.166

4.  Comparison of positron emission tomography (PET) and computed tomography (CT) for better target volume definition in radiation therapy planning.

Authors:  Antoni Vila; Alberto Sánchez-Reyes; Carles Conill; Juan Domingo Gispert; Carlos Trampal; Carmen Láinez; Jordi Vayreda; Agustí Pedro
Journal:  Clin Transl Oncol       Date:  2010-05       Impact factor: 3.405

5.  Radiosensitization effects by bismuth oxide nanorods of different sizes in megavoltage external beam radiotherapy.

Authors:  Amirah Jamil; Safri Zainal Abidin; Khairunisak Abdul Razak; Hafiz Zin; Muhammad Amir Yunus; Wan Nordiana Rahman
Journal:  Rep Pract Oncol Radiother       Date:  2021-09-30

6.  The imaging probe development center and the production of molecular imaging probes.

Authors:  Gary L Griffiths
Journal:  Curr Chem Genomics       Date:  2008-06-13

Review 7.  18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.

Authors:  Eric C Ford; Joseph Herman; Ellen Yorke; Richard L Wahl
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

8.  Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.

Authors:  Paul Okunieff; Lisa A Kachnic; Louis S Constine; Clifton D Fuller; Laurie E Gaspar; Daniel F Hayes; Jean Hooks; Clifton Ling; Frank L Meyskens; Philip A Philip; David Raben; Stephen R Smalley; Gregory P Swanson; Beverly A Teicher; Charles R Thomas; Bhadrasain Vikram; Michael J Zelefsky; Laurence H Baker
Journal:  Clin Cancer Res       Date:  2009-09-01       Impact factor: 12.531

9.  IMRT: preliminary results in a series of advanced head-and-neck cancer patients.

Authors:  Antonio Vila Capel; Jorge Vilar Palop; Agustín Pedro Olivé; Alberto Sanchez-Reyes Fernandez; Jordi Vayreda Ribera; Joan Carles Julià Sanahuja; Joaquim Pérez de Olaguer Agustín; Nuria Artola Codina; Luis Miguel Moya Cascant; Esther Rubio Calatayud; Gemma Carrera Domenech
Journal:  Clin Transl Oncol       Date:  2012-07-27       Impact factor: 3.405

10.  Technical note: 9-month repositioning accuracy for functional response assessment in head and neck chemoradiotherapy.

Authors:  M Partridge; C Powell; M Koopman; L Humbert Vidan; K Newbold
Journal:  Br J Radiol       Date:  2012-12       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.